About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
Previous Close | $16.47 | Open | $16.67 |
Volume | 875.6K | Market Cap | 499.41M |
Yield | Last Dividend |
CEL-SCI Corporation Reports First Quarte... | 02/16/21 |
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation reports first quarter fiscal 2021 financial results. |
88 Biggest Movers From Friday | 02/01/21 |
Gainers Siebert Financial Corp. (NASDAQ: SIEB ) shares climbed 121.6% to close at $8.22 on Friday on heavy volume. Catabasis Pharmaceuticals, Inc. (NA... |
CEL-SCI Corporation to Present at the 20... | 01/08/21 |
CEL-SCI Corporation to Present at the 2021 H.C. Wainwright BIOCONNECT Virtual Conference |
CEL-SCI Corporation Issues Letter to Sha... | 01/04/21 |
CEL-SCI Corporation issues letter to shareholders. |
CEL-SCI Corporation to Present at the 13... | 12/14/20 |
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation to Present at the 13th Annual LD Micro Main Event Conference |
CVR Medical : IIROC Trading Resumption -... | 11/06/20 |
Halts/Resumptions?? Canada Newswire, source Canada Newswire English??? | November 6, 2020 |
CEL-SCI Corporation Issues Letter to Sha... | 09/15/20 |
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation issues letter to shareholders. |
CEL-SCI Corporation to Present at H.C. W... | 09/11/20 |
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation to Present at H.C. Wainwright 22nd Annual Global Investment Conference |
Important Update For CEL-SCI Corporation... | 04/08/20 |
VIENNA, Va.--(BUSINESS WIRE)--Important update for CEL-SCI Corporation Annual Meeting of Shareholders. |
CVR Medical : Announces Trish Howell to ... | 03/16/20 |
VANCOUVER, BC / March 10, 2020 / / CVR Medical Corp. a Canadian listed and US based healthcare company in the medical device sector announces the resi... |
CVR Medical : Announces Acquisition of a... | 03/16/20 |
VANCOUVER, BC / March 16, 2020 / / CVR Medical Corp. a Canadian listed and US based healthcare company in the medical device sector announces the plan... |
SHAREHOLDER ALERT: Levi & Korsinsky, LLP... | 03/10/20 |
NEW YORK, NY / ACCESSWIRE / March 10, 2020 / Levi & Korsinsky announces it has commenced an investigation of CEL-SCI Corporation (NYSE:CVM) concerning... |
CEL-SCI Corporation Reports First Quarte... | 02/10/20 |
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation reports first quarter fiscal 2020 financial results. |
CVR Medical : Provides Corporate Update ... | 01/06/20 |
VANCOUVER, BC / January 6, 2020 / CVR Medical Corp. a Canadian listed and US based healthcare company in the medical device sector provides the follow... |
US??? CEL-SCI Corporation closes $5.5m u... | 12/27/19 |
Mubasher: American biotechnology company CEL-SCI Corporation has announced that it closed an underwritten public offering of 606,395 shares of its com... |
CEL-SCI Dips on Stock Offering | 12/24/19 |
CEL-SCI Corporation (NYSE:CVM) reported a common stock offering Tuesday. The company, located in Vienna, Virginia, is a Phase 3 cancer immunotherapy c... |
4 Stocks To Watch For December 24, 2019 | 12/24/19 |
Some of the stocks that may grab investor focus today are: CEL-SCI Corporation (NYSE: CVM ) reported a common stock offering. However, size of the off... |
CEL-SCI: Why No Discussions About Yervoy... | 12/04/19 |
CEL-SCI Corporation (CVM) is a small-cap (~$250million), clinical-stage cancer bio-pharmaceutical company. Multikine, a cocktail combination of cytoki... |
CVR Medical : Announces Revocation of Ce... | 11/05/19 |
DENVER, NC / November 5th, 2019, / CVR Medical Corp. a Canadian listed and US based healthcare company in the medical device sector is pleased to anno... |
CEL-SCI Corporation to Present at Dawson... | 10/29/19 |
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation to present at Dawson James Securities 5th Annual Small Cap Growth Conference. |
The Dangers Of CEL-SCI Corporation | 05/16/19 |
No summary available. |
CEL-SCI (CVM) Presents At BIO CEO & Inve... | 02/12/19 |
The following slide deck was published by Cel-Sci Corporation in conjunction with this event. |
Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
Total Revenue | $1.3B | Total Liabilities | $2.1B |
Cost of Revenue | $2.5B | Total cash flow | $3.2 |
Total Assets | $29.98B |
% Insider | 12.52% | % Institutional | 76.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Service Name | Trader | % Success | |
---|---|---|---|
Arbitrage Trade Analytics | Royce Wells | 72.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.